Alterations in the circadian blood pressure pattern are frequently observed in hypertension and lead to increased cardiovascular morbidity. However, there are no studies that have investigated a possible implication of the Period2 gene, a key component of the molecular circadian clock, on the circadian rhythms of blood pressure and heart rate. To address this question, we monitored blood pressure, heart rate, and locomotor activity 24 h a day by telemetry in mice carrying a mutation in the Period2 gene and in wild-type control mice. Under a standard 12:12-h light-dark cycle, mutant mice showed a mild cardiovascular phenotype with an elevated 24-h heart rate, a decreased 24-h diastolic blood pressure, and an attenuation of the dark-light difference in blood pressure and heart rate. Locomotor activity was similar in both groups and did not appear to explain the observed hemodynamic differences. When mice were placed under constant darkness during eight consecutive days, wildtype mice maintained 24-h rhythms, whereas there was an apparent progressive loss of 24-h rhythm of blood pressure, heart rate, and locomotor activity in mutant mice. However, a chi square periodogram revealed that circadian rhythms were preserved under complete absence of any light cue, but with shorter periods by ϳ40 min, leading to a cumulative phase shift toward earlier times of ϳ5 h and 20 min by the end of the 8th day. When heart rate, mean arterial pressure, and activity were recalculated according to the endogenous circadian periods of each individual mouse, the amplitudes of the circadian rhythms ("subjective night"-"subjective day" differences) were maintained for all variables studied. Our data show that mutation of the Period2 gene results in an attenuated dipping of blood pressure and heart rate during both light-dark cycles and constant darkness, and in shorter circadian periods during constant darkness. circadian rhythm; clock genes; heart rate; blood pressure; telemetry CIRCULATORY DEMANDS CHANGE greatly over the day and night, and the ability to anticipate these changes is beneficial to the survival of the individual. Blood pressure (BP), heart rate (HR), cardiac output, and stroke volume change rhythmically according to a 24-h cycle, in humans being higher during the day than during the night (20, 23) . A number of studies provide evidence that the endogenous circadian oscillating system in the suprachiasmatic nucleus (SCN) plays an important role in cardiovascular control as SCN lesion eliminates 24-h rhythm of BP and HR in experimental animals (15, 36, 37) .
circadian clock are suggested in human hypertension (12, 13) and in some animal models of hypertension (9, 10) . Hypertensive patients whose average night-time BP fails to "dip" relative to their average daytime BP by at least 10% ("nondippers") have a significantly greater frequency of left ventricular hypertrophy, microalbuminuria, and stroke (14, 29, 41) than do individuals whose BP drops during the night by 10% or more.
In mammals, circadian rhythms of physiology, biochemistry, and behavior are orchestrated by a master clock situated in the SCN of the hypothalamus (49) . The endogenously generated circadian rhythm maintains a period of ϳ24 h even in the absence of environmental cues (33) . Molecular circadian regulation engages a transcription-translation feedback loop comprising clock proteins, CLOCK, BMAL1, PER(s), and CRY(s) (4, 8, 40) . Circadian expression of clock genes has also been demonstrated throughout the body, such as in the heart (38) , liver (19) , adrenal cortex (6) , or kidney and other organs (5) .
The Period 2 (Per2) gene is a key molecular component in controlling mammalian circadian rhythms (2) at the levels of gene expression, physiology, and pathology. A robust circadian fluctuation of Per2 mRNA expression was discovered not only in the SCN but also in many peripheral tissues. The Per genes are crucial for circadian phase shifts by delaying the clock phase and regulates expression of another clock gene (Bmal1) in a positive manner. Furthermore, alterations in Per2 genes affect many biochemical processes, showing the multiple facets of the Per2 gene (reviewed in Ref. 3) . The behavioral phenotype of Per2 mutants in constant darkness is characterized by short period rhythms and a progressive loss of the circadian rhythm of wheel-running locomotor activity (51) . In addition, a lack of food anticipation (seen through the lack of food-anticipatory activity and lack of body temperature changes in anticipation of food) is specifically associated with a mutation of Per2, demonstrating the critical involvement of this gene in the anticipation of meal time (11) . Several authors have already suggested the potential involvement of Per2 gene in regulation of the cardiovascular system. It was shown that the protein encoded by Per2 gene (PER2) is expressed in a circadian manner in aortic smooth muscle cells (32) and that disturbed diurnal rhythm alters Per2 gene expression both in SCN and the heart of a mouse model of pressure overload cardiac hypertrophy (22) . In addition, Per2 mutant mice display altered vascular endothelial function (48) . However, there are no studies that have directly analyzed the role of the Per2 gene on the circadian control of BP and HR. To address this question, we analyzed, in Per2 mutant mice and wild-type control mice, the circadian rhythms of BP, HR, and locomotor activity, both in the presence and in the absence of the most powerful external cue, i.e., the light-dark (LD) cycle.
METHODS
Animals. Mutant mice (mPer2Brdm1), designated here as Per2 mutants, were obtained from Zheng et al. (51) and propagated in our own facility. In Per2 mutants, PER2 protein is lacking the COOHterminal half of the PAS B and the entire PAC domain, resulting in a significantly shortened protein that lacks possible dimerization sites (reviewed in Ref. 3) . All experiments were performed on adult 3-to 4-mo-old wild-type (WT) (129 SvEvBrd X C57B16-Ty) and Per2 mutant mice. In this study, we used only male mice to avoid estrousrelated variations in the circadian pattern of BP, HR, and locomotor activity that have been described in female rats (43, 50) and mice (17) . Homozygous mutants and wild types were kept on an artificial 12:12-h LD cycle with lights off from 1800 to 0600. Temperature and humidity were kept stable at 22 Ϯ 1°C and 55 Ϯ 5%, respectively. Animals were housed individually and provided with normal chow (Diet 3433; Provimi-Kliba) and water ad libitum. The animal experimental protocol was approved by the Ethical Committee of the State Veterinary Office of Fribourg, Switzerland.
BP telemetry. All surgical procedures were performed using aseptic techniques, premedication with 0.03 mg/kg atropine sulfate ϩ 10 mg/kg im carprofen, and under general anesthesia with 90 mg/kg ketamine ϩ 10 mg/kg ip xylazine. All mice were instrumented with an arterial catheter connected to an implantable transducer (model TA11PA-C10; Data Sciences International, St. Paul, MN) to monitor arterial pressure and HR 24 h a day by telemetry in unrestrained mice. The tip of the telemeter catheter was inserted in the aortic arch via the left common carotid artery as described previously (46) . After completion of the procedure, the mice were housed in individual standard mouse cages (23 cm ϫ 17 cm ϫ 14 cm high; Indulab) for continuous BP and HR measurement and monitoring of daily food intake. At least 12 days were given for animals to recover from surgery and for BP and HR to stabilize.
Animal cages were equipped with one RPC-1 plastic receiver (Data Sciences International) fixed on the bottom of the cage and connected to an analog output device (R11-CPA), allowing for the continuous recording of the analog pulsatile arterial pressure signal. The signal was then fed to a 12-bit analog-to-digital converter, sampled at 1 kHz, and processed using customized algorithms for beat-to-beat analysis (24) . Locomotor activity was estimated from the number of counts provided by the receiver, reflecting movements of the animal above a certain threshold. Each telemeter transducer was calibrated before implantation, as well as after explantation. Corrections for offset drift were not needed because the drift was Ͻ2 mmHg in all mice.
Experimental protocol. In all animals (27 Per2 mutants and 30 WT control mice) we studied basal HR, BP, and locomotor activity under the standard 12:12-h LD cycle during two consecutive days (protocol 1). In a subset of animals (9 Per2 mutants and 6 WT mice), we studied the effects of constant darkness (DD) on circadian periods of cardiovascular parameters (protocol 2). After 2 days of control under 12:12-h LD cycle in a customized ventilated chamber, mice were submitted to eight consecutive days of DD, with no exposure to external cues (noise or light) and with enough food and water to sustain the 8 days of DD. This was followed by a 3-day recovery under a regular 12:12-h LD cycle.
Measurements under DD. Comparison of six methods for the determination of the period of circadian rhythm (Fourier analysis, autocorrelation, chi-square periodogram, linear regression of onset, interonset averaging, and acrophase counting) revealed that Fourier analysis and chi-square periodogram were superior to the other methods in the analysis of more complex waveforms (which more closely resemble actual circadian rhythms) (30) . Furthermore, when random noise was inserted in the original data set, the chi-square periodogram was more tolerant to low signal-to-noise ratio than Fourier analysis. Thus we used the chi-square periodogram (30, 31) to calculate circadian periods of mean arterial pressure (MAP), HR, and activity for the eight consecutive days under DD. A resolution of 10 min (bin size) under DD was selected as input data, which give a 0.17-h resolution of the computed periods.
First, the daily 24-h records for both LD and DD experimental days were divided in two equal periods of 12 h, from 1800 to 0600 (ZT12 to ZT24, representing "night") and from 0600 to 1800 (ZT0 to ZT12, representing "day") to compute daily mean night minus mean day differences, defined here as night-day difference. ZT stands for "Zeitgeber time", i.e., time defined relative to the experimental LD cycle where the onset of light defines the Zeitgeber time 0 (ZT0) and the onset of dark defines Zeitgeber time 12 (ZT12). Next, the circadian periods of HR, MAP, and activity under DD, obtained by the chisquare periodogram, were used to calculate the "subjective" day/night cycle of each individual mouse and divided in two equal periods corresponding to "subjective day" (CT0 to CT12) and "subjective night" (CT12 to CT24) for these parameters. Again, we computed mean subjective night minus mean subjective day differences, defined here as the subjective night-subjective day difference and plotted over CT, where CT stands for "circadian time," i.e., standard of time based on the free-running period of a rhythm where the onset of activity defines circadian time 12 (CT12).
A second analysis program (cosinor periodogram by R. Refinetti, http://www.circadian.org/softwar.html) was used to compare the circadian periods between LD and DD. This was necessary because the chi-square periodogram, although the most reliable tool when a sufficient number of input days is available, was not able to compute the period of circadian rhythms from only 2 days of the LD cycle.
Finally, to compute the acrophase (time at which the peak of the rhythm is reached) and the threshold (time at which the trough of the rhythm is reached), we used a fitted cosine wave procedure (Acro program by R. Refinetti, http://www.circadian.org/softwar.html) for both LD and each of the 8 days under DD. The times of acrophase and threshold are given in hours from midnight.
Statistical analysis. All data are presented as means Ϯ SE. In protocol 1, an unpaired t-test was used to compare data between Per2 mutants and WT mice. In protocol 2, daily changes from control baseline values were analyzed with an analysis of variance for repeated measurements, followed by a multiple-comparisons Dunnett's t-test. Comparisons between Per2 mutants and WT mice were done with an unpaired t-test, with Bonferroni correction in the case of 
RESULTS

Basal hemodynamic values under 12:12-h LD cycle (protocol 1)
. Basal values collected during two consecutive days of the 12:12-h LD cycle (protocol 1) for MAP, systolic and diastolic pressures (SBP and DBP, respectively), HR, and locomotor activity are given in Table 1 . Data are presented as 24-h averages and separately for the light and the dark periods. Twenty-four-hour HR was higher in Per2 mutant mice than in WT mice. BP tended to be lower in mutant mice, but this was significant only for DBP. When analyzing light and dark periods separately, the increase in HR was confined to the light period, whereas the decrease in DBP was significant only during the dark period. Mean locomotor activity (expressed as the number of activity signals received/30 s) was similar in both types of mice.
To assess the influence of locomotor activity on hemodynamic parameters, we reanalyzed the data by separating the 30-s periods in which the animal was moving (active periods) from the periods in which no apparent movements were detected (inactive periods), as shown in Table 2 . The higher HR in Per2 mutants seemed more related to the resting state, since the difference in HR between WT and mutant mice was greater during periods of inactivity (see Table 2 ). On the other hand, DBP tended to be lower in Per2 mutants when the animals were active. Although mean locomotor activity was similar in both types of mice (Table 1) , Per2 mutants showed a slightly higher percentage of time spent active during the light period (Table 2) .
Differences between the 12-h dark period and the 12-h light period (dark-light difference) were computed and are reported in Fig. 1 . Per2 mutants showed significant decreases in dark- light differences for MAP (Fig. 1A , P ϭ 0.002) and HR ( Fig. 1B , P ϭ 0.0004), but not of locomotor activity (Fig. 1C) . Dark-light differences were also significantly smaller for SBP and DBP (P ϭ 0.01 and P Ͻ 0.0001, respectively; data not shown). Figure 2 shows the calculated circadian periods by chi-square periodogram in WT and Per2 mutant mice during DD when all eight consecutive days were pooled for a single analysis of the duration of the average circadian period. In WT mice, circadian periods were fully preserved and amounted to ϳ24 h for MAP The calculated circadian periods by cosinor periodogram in WT and Per2 mutant mice both during LD (pool of 2 consecutive days) and during DD (pool of 8 consecutive days) are shown in Table 3 . Under LD, there were no differences in the circadian periods between WT mice and Per2 mutants for all three variables studied (MAP, HR, and activity). During DD, however, Per2 mutants had significantly shorter circadian periods of MAP, HR, and activity compared with WT counterparts. Comparing DD vs. LD, WT mice showed similar circadian periods, whereas Per2 mutants had shorter circadian periods (but significant only for MAP and HR). Figure 3 , left (A1, B1, and C1), shows the 12:12-h night-day difference for MAP, HR, and locomotor activity during the two control days under the 12:12-h LD cycle, during the 8 days of DD, and during the first 3 days of recovery under the 12:12-h LD cycle. All data are plotted over ZT time, i.e., relative to the experimental LD cycle. During DD, WT mice showed a preserved 12:12-h night-day difference for MAP, HR, and locomotor activity during all 8 days of DD. In contrast, Per2 mutant mice showed a progressive alteration of the 12:12-h night-day difference for all three variables studied (Fig. 3, A1 , B1, and C1). When the animals were returned to a normal 12:12-h LD cycle (3 days of recovery), WT mice maintained their stable night-day differences, and Per2 mutant mice showed a progressive return of the night-day differences toward basal control values.
Hemodynamic analysis under DD (protocol 2).
Because of the shorter circadian periods computed in Per2 mutants, night-day differences under DD were recalculated on the basis of the endogenous (i.e., free-running) circadian periods of MAP, HR, and activity obtained for each individual mouse by the chi-square periodogram and are expressed as the subjective night-subjective day difference. As shown in Fig. 3 , right (A2, B2, and C2), the time axis represents now, not a 24-h time based on a 12:12-h LD cycle (ZT), but CT. Thus the beginning of the subjective day is at CT0, and the beginning of the subjective night is at CT12. Recalculated data showed that Per2 mutant mice were able to conserve circadian rhythms of all three variables under DD. Because circadian periods in mutant mice under DD were significantly shorter than 24 h, the mice were already in subjective day for ϳ5 h and 20 min at the Fig. 2 . Circadian rhythm periods as assessed by a chi-square periodogram over the 8 consecutive days of constant darkness for MAP (A), HR (B), and locomotor activity (C) (n ϭ 6 for wild-type mice, n ϭ 9 for Per2 mutant mice, except n ϭ 7 for locomotor activity). In two Per2 mutant mice, the periodogram for locomotor activity did not yield a period length because of arrhythmicity. **P Ͻ 0.01 and ***P Ͻ 0.001 compared with wild type. Values for individual mice are plotted as separate symbols. beginning of the light period upon return to a normal 12:12-h LD after 8 days under DD. Thus it was not possible to calculate the night-day difference according to the circadian periods during the 3 days of recovery. The two control days under the 12:12-h LD cycle are the same for all panels, since here CT ϭ ZT. Figure 4 shows the acrophase and the threshold of the rhythms for MAP (Fig. 4A), HR (Fig. 4B) , and activity (Fig. 4C) . Data are plotted in hours from midnight during LD (as average for 2 control days) and for each of the 8 days under DD. In WT mice, both the acrophase and the threshold of the rhythms during all 8 days of DD remained similar to the LD value. In contrast, Per2 mutants showed a progressive shift from LD that by the 8th day led to a cumulative advanced time shift of 4.9 h for MAP threshold (from 14.2 to 9.3 h) and 5.1 h for MAP acrophase (from 22.6 to 17.5 h). Similar results were found for HR threshold (5.4-h advanced shift, from 12.5 to 7.1 h) and HR acrophase (5.8-h advanced shift, from 21.1 to 15.3 h), as well as for activity threshold (5.8-h advanced shift, from 13.4 to 7.6 h) and activity acrophase (6-h advanced shift, from 21.9 to 15.9 h).
DISCUSSION
The present study focused on the possible role of the clock gene Per2 in the circadian control of BP and HR, since this gene is considered to be a key component of the molecular circadian clock (1, 16) . The most important findings of our study are that mutation of the Per2 gene results in an attenuation of the dark-light difference in BP and HR during both LD cycles and constant darkness, and shorter circadian periods of BP, HR, and locomotor activity under DD.
Under a standard LD cycle, Per2 mutant mice showed a cardiovascular phenotype characterized by a higher HR during Fig. 3 . Left: "night"-"day" differences in MAP (A1), HR (B1), and locomotor activity (C1) when plotted over 12:12-h cycles (Zeitgeber time, ZT) before, during, and after of 8 days of constant darkness (DD). LD, light-dark cycle. Right: "subjective night"-"subjective day" difference obtained from the same data based on recalculated individual circadian periods (circadian time, CT) (n ϭ 6 for wild-type mice, n ϭ 9 for Per2 mutant mice, except n ϭ 7 for locomotor activity under DD). *P Ͻ 0.05 and §P Ͻ 0.001 compared with control LD baseline values.
the light period, a lower DBP during the dark period, and a decreased dark-light difference in BP and HR. Because locomotor activity may represent a very important confounding factor in the analysis of BP and HR, particularly in mice (46, 47), we also compared hemodynamic values during periods of activity and inactivity, as shown in Table 2 . Intriguingly, the increase in HR during the light period and the decrease in DBP during the dark period were found during both active and inactive periods, suggesting that locomotor activity is not the major determinant of the phenotype difference between Per2 mutant and WT mice. Furthermore, the average intensity of locomotor activity in Per2 mutants was not statistically different from that of WT mice under LD conditions (see Table 1 ) despite a slightly greater percentage of time spent in active periods during the light period (see Table 2 ). These data are consistent with previous observations that Per2 mutant animals do not differ in the amount of wheel running activity from their WT counterparts (27) . In addition, the Per2 mutant mice have a tendency for lower BP, which was significant only for DBP during the dark period. This was unexpected since we previously described that isolated vessels of Per2 mutant mice display altered vascular endothelial function because of a decreased production of nitric oxide and vasodilatory prostaglandins and an increased release of cyclooxygenase-1-derived vasoconstrictors (48) . This could suggest that BP regulation is not dominated by peripheral clocks in blood vessels.
Another interesting finding under the LD cycle was an attenuation of the dark-light difference in Per2 mutants that was statistically significant for MAP and HR, but not for locomotor activity (Fig. 1) . We can only speculate on the causes of the attenuated dark-light difference. A possible explanation is an autonomic imbalance with an attenuation of sympathetic inhibition during the light period, consistent with the higher HR observed during this period. In fact, the autonomous nervous system is probably the most important mechanism by which the SCN controls the circadian rhythm of BP and HR (7, 38, 44) . In humans, deregulation of the circadian control of the autonomic nervous system may lead to a nondipping pattern of BP associated with and potential targetorgan damage in hypertensive patients (29, 41) and, more recently published, in normotensive subjects (42) .
As shown in Table 3 , a 24-h rhythm was preserved during LD in Per2 mutants and did not differ from WT mice. To assess free-running circadian rhythms in the absence of the most powerful external cue (Zeitgeber), i.e., the LD cycle, it is important to study animals under constant conditions. It is known that Per2 mutants under DD have a shorter circadian rhythm period of wheel-running activity than their WT counterparts (51). However, free-running circadian rhythm periods of BP and HR in Per2 mutants have not been reported. When both types of mice were placed under DD during eight consecutive days, WT mice conserved circadian rhythm amplitudes, whereas there was an apparent progressive attenuation of BP, HR, and locomotor activity rhythm amplitudes in mutant mice. However, based on both chi-square and cosinor periodogram analyses, a circadian period for all three variables studied (MAP, HR, and locomotor activity) was observed in Per2 mutant mice, but was significantly shorter than in WT counterparts, as shown in Fig. 2 and Table 3 . This shortening could be because of a defect in the central clock. Indeed, expression of Per2 in SCN of WT controls peaks at around ZT12 and in Per2 mutants at around ZT10 (51) . This phase advance of Per2 expression in SCN could be responsible for the phase advance in daily rhythms observed in Per2 mutants. Furthermore, patients with a mutation in the binding site for , and locomotor activity (C) for control LD cycle and for each individual of 8 days of DD (n ϭ 6 for wild-type mice, n ϭ 9 for Per2 mutant mice except, n ϭ 7 for locomotor activity under DD). §P Ͻ 0.05 compared with control LD baseline values. *P Ͻ 0.05 compared with wild-type mice.
casein kinase 1 in the Per2 gene show a familial advanced sleep phase syndrome (45) . A daily shortening of circadian rhythms observed in our experiments would lead to a cumulative advanced phase shift of the subjective day/night cycle by the 8th day of DD, explaining the progressive attenuation in the circadian amplitudes seen in Fig. 3, A1-C1 , when data are plotted based on ZT. When data were plotted using CT instead of ZT, Per2 mutants cannot be considered to be arrhythmic, at least not for the first 8 days under DD, based on the preservation of the amplitude of the circadian rhythms of MAP, HR, and activity (Fig. 3, A2-C2 ). On the other hand, WT mice maintained a 24-h rhythm even under the complete absence of any light cue. This finding is supported by the results seen in Fig. 4 showing that the acrophase and the threshold of the rhythms in the WT mice under DD appeared at the same time of the day as in the LD period. In contrast, Per2 mutants showed a progressive advanced shift of the both acrophase and the threshold, leading to an average cumulative shift of between 5 and 6 h by the end of the 8th day. This advanced shift in acrophase and threshold is consistent with the ϳ5 h and 20 min phase-advanced shift obtained with the chi-square periodogram. Moreover, the shortening of the rhythms seems to occur from the very first day of DD based on acrophase and threshold values in Fig. 4 .
The shorter periods of BP and HR in Per2 mutants are probably not linked to the shorter period of activity. First, a loss of the circadian rhythm of wheel-running activity in Per2 mutants can occur very early (range between 2 and 18 days) upon introduction of DD (51) . Second, two Per2 mutant mice in our study did not show a rhythm for locomotor activity with the chi-square periodogram but had rhythms for MAP and HR during 8 days of DD. This could imply that circadian locomotor activity rhythm is decoupled from MAP and HR rhythms in Per2 mutant mice, and probably is the first one to be lost under constant conditions. The maintenance of HR circadian rhythms even when activity rhythms were lost is consistent with the finding in humans that the circadian rhythm in HR could be independent of the activity rhythm (18, 39) . WT mice circadian period lengths under DD were very consistent for all animals. As shown in Fig. 2 , the highest value for MAP in the circadian period was 24.00 h and the lowest value was 23.73 h. A similar narrow range was found for HR (highest value 24.33 h, lowest value 23.83 h) and for activity (highest value 24.5 h, lowest value 23.83 h). In contrast, Per2 mutant mice showed a wide distribution of the same parameters with MAP period ranging from 22.70 to 23.97 h, HR period ranging from 23.00 to 23.62 h, and locomotor activity period ranging from 22.50 to 24.00 h. This lack of uniformity among period lengths in Per2 mutants further enhances the alteration of night-day differences under DD when a 12:12-h ZT cycle is used to calculate the data.
Substantial evidence has accumulated that the SCN orchestrates circadian oscillations in sympathetic and parasympathetic activity, and alterations in its function may thereby affect the cardiovascular system. Deregulation of the circadian control of the endocrine system, mainly of the reactivity of the hypothalamicpituitary-adrenal axis, may further impair the adaptation of the cardiovascular system to external challenges. Moreover, alterations in the peripheral circadian clock mechanisms, particularly in the heart, kidney, and vascular smooth muscle cells, may compromise the harmonious regulation of cardiovascular function and jeopardize its ability to adapt to circadian changes in exogenous demands. However, their quantitative contribution to the Per2 phenotype is not clear.
Perspectives
Epidemiological evidence shows that cardiovascular events occur more frequently at certain periods of the day in humans. A number of cardiovascular pathologies such as myocardial ischemia (35) , myocardial infarction (26) , sudden cardiac death (25) , and ischemic stroke (21) show a diurnal pattern. Furthermore, circadian rhythm disruption is found commonly in patients with sleep apnea (28) , transmeridian flight crews, and shift workers (34) , all of whom show higher than average prevalence of cardiovascular diseases. A better understanding in the control of cardiovascular circadian rhythms may lead to health benefits. Our present results suggest that the Per2 gene provides a significant contribution to cardiovascular circadian rhythms.
